FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3036825423> ?p ?o ?g. }

• W3036825423 abstract "Cytokine release syndrome (CRS) is known to be a factor in morbidity and mortality associated with acute viral infections including those caused by filoviruses and coronaviruses. IL-6 has been implicated as a cytokine negatively associated with survival after filovirus infection. However, IL-6 has also been shown to be an important mediator of innate immunity, important for the host response to an acute viral infection. Clinical studies are now being conducted by various researchers to evaluate the possible role of IL-6 blockers to improve outcomes in critically ill patients with SARS-CoV-2 infection. Most of these studies involve the use of anti-IL-6R monoclonal antibodies (mAbs). We present data showing that direct neutralization of IL-6 with an anti-IL-6 mAb in a BALB/c Ebolavirus (EBOV) challenge model produced a statistically significant improvement in outcome compared with controls when administered within the first 24 hours of challenge and repeated every 72 hours. A similar effect was seen in mice treated with the same dose of anti-IL-6R mAb when the treatment was delayed 48 hrs post-challenge. These data suggest that direct neutralization of IL-6, early during the course of infection, may provide additional clinical benefits to IL-6 receptor blockade alone during treatment of patients with virus-induced CRS. These results may have implications for selecting and managing IL-6 blockade therapy for patients with COVID-19." @default.
• W3036825423 created "2020-06-25" @default.
• W3036825423 creator A5003314954 @default.
• W3036825423 creator A5004257072 @default.
• W3036825423 creator A5023516845 @default.
• W3036825423 creator A5032512035 @default.
• W3036825423 creator A5033010701 @default.
• W3036825423 creator A5033593951 @default.
• W3036825423 creator A5035696262 @default.
• W3036825423 creator A5037761984 @default.
• W3036825423 creator A5043216829 @default.
• W3036825423 date "2020-06-21" @default.
• W3036825423 modified "2023-09-23" @default.
• W3036825423 title "Anti-IL-6 versus anti-IL-6R Blocking Antibodies to Treat Acute Ebola Infection in BALB/c Mice with Potential Implications for Treating Patients Presenting with COVID-19" @default.
• W3036825423 cites W1553047467 @default.
• W3036825423 cites W1966742128 @default.
• W3036825423 cites W1993965822 @default.
• W3036825423 cites W2002815968 @default.
• W3036825423 cites W2025492877 @default.
• W3036825423 cites W2070463916 @default.
• W3036825423 cites W2070607735 @default.
• W3036825423 cites W2082708772 @default.
• W3036825423 cites W2121706409 @default.
• W3036825423 cites W2143037496 @default.
• W3036825423 cites W2471732223 @default.
• W3036825423 cites W2473956191 @default.
• W3036825423 cites W2560068917 @default.
• W3036825423 cites W2781494357 @default.
• W3036825423 cites W2913102905 @default.
• W3036825423 cites W2991498365 @default.
• W3036825423 cites W3001118548 @default.
• W3036825423 cites W3002108456 @default.
• W3036825423 cites W3009314935 @default.
• W3036825423 cites W3009885589 @default.
• W3036825423 cites W3012421327 @default.
• W3036825423 cites W3013653866 @default.
• W3036825423 cites W3014823176 @default.
• W3036825423 cites W3016263512 @default.
• W3036825423 cites W3017340845 @default.
• W3036825423 cites W3020089922 @default.
• W3036825423 cites W3022970339 @default.
• W3036825423 cites W3026277345 @default.
• W3036825423 doi "https://doi.org/10.7916/d8-ep49-2n35" @default.
• W3036825423 hasPublicationYear "2020" @default.
• W3036825423 type Work @default.
• W3036825423 sameAs 3036825423 @default.
• W3036825423 citedByCount "0" @default.
• W3036825423 crossrefType "posted-content" @default.
• W3036825423 hasAuthorship W3036825423A5003314954 @default.
• W3036825423 hasAuthorship W3036825423A5004257072 @default.
• W3036825423 hasAuthorship W3036825423A5023516845 @default.
• W3036825423 hasAuthorship W3036825423A5032512035 @default.
• W3036825423 hasAuthorship W3036825423A5033010701 @default.
• W3036825423 hasAuthorship W3036825423A5033593951 @default.
• W3036825423 hasAuthorship W3036825423A5035696262 @default.
• W3036825423 hasAuthorship W3036825423A5037761984 @default.
• W3036825423 hasAuthorship W3036825423A5043216829 @default.
• W3036825423 hasConcept C126322002 @default.
• W3036825423 hasConcept C14086860 @default.
• W3036825423 hasConcept C159047783 @default.
• W3036825423 hasConcept C159654299 @default.
• W3036825423 hasConcept C170493617 @default.
• W3036825423 hasConcept C203014093 @default.
• W3036825423 hasConcept C2522874641 @default.
• W3036825423 hasConcept C2777469322 @default.
• W3036825423 hasConcept C2777701055 @default.
• W3036825423 hasConcept C2778468042 @default.
• W3036825423 hasConcept C2778690821 @default.
• W3036825423 hasConcept C2779134260 @default.
• W3036825423 hasConcept C2779341262 @default.
• W3036825423 hasConcept C2779559532 @default.
• W3036825423 hasConcept C2780850621 @default.
• W3036825423 hasConcept C2909623084 @default.
• W3036825423 hasConcept C3008058167 @default.
• W3036825423 hasConcept C3875195 @default.
• W3036825423 hasConcept C524204448 @default.
• W3036825423 hasConcept C542903549 @default.
• W3036825423 hasConcept C71924100 @default.
• W3036825423 hasConcept C8891405 @default.
• W3036825423 hasConceptScore W3036825423C126322002 @default.
• W3036825423 hasConceptScore W3036825423C14086860 @default.
• W3036825423 hasConceptScore W3036825423C159047783 @default.
• W3036825423 hasConceptScore W3036825423C159654299 @default.
• W3036825423 hasConceptScore W3036825423C170493617 @default.
• W3036825423 hasConceptScore W3036825423C203014093 @default.
• W3036825423 hasConceptScore W3036825423C2522874641 @default.
• W3036825423 hasConceptScore W3036825423C2777469322 @default.
• W3036825423 hasConceptScore W3036825423C2777701055 @default.
• W3036825423 hasConceptScore W3036825423C2778468042 @default.
• W3036825423 hasConceptScore W3036825423C2778690821 @default.
• W3036825423 hasConceptScore W3036825423C2779134260 @default.
• W3036825423 hasConceptScore W3036825423C2779341262 @default.
• W3036825423 hasConceptScore W3036825423C2779559532 @default.
• W3036825423 hasConceptScore W3036825423C2780850621 @default.
• W3036825423 hasConceptScore W3036825423C2909623084 @default.
• W3036825423 hasConceptScore W3036825423C3008058167 @default.
• W3036825423 hasConceptScore W3036825423C3875195 @default.
• W3036825423 hasConceptScore W3036825423C524204448 @default.
• W3036825423 hasConceptScore W3036825423C542903549 @default.
• W3036825423 hasConceptScore W3036825423C71924100 @default.

• next